Table 3.
Selected published series including patients who underwent open NSS or RN for renal masses due to their tumor size (table modified from [14]).
| Author | Reference | Year | N | Local recurrence (%) | 5-year dfs (mos) | |||
|
| ||||||||
| Tumor size <4 cm in size* | ||||||||
|
| ||||||||
| Hafez et al. | [26] | 1999 | 310 | 0.6 | 96 | |||
| Lee et al. | [27] | 2000 | 79 | 0 | 100 | |||
| McKiernan et al. | [24] | 2002 | 117 | 1.2 | 100 | |||
| Patard et al. | [18] | 2004 | 314 | 0.8 | 98 | |||
|
| ||||||||
| Tumor size >4 cm in size** | ||||||||
|
| ||||||||
| Hafez et al. | [26] | 1999 | 175 | 0.8 | 86 | |||
| Patard et al. | [18] | 2004 | 65 | 3.6 | 94 | |||
| Leibovich et al. | [28] | 2004 | 91 | 5.4 | 98 | |||
| Becker et al. | [29] | 2006 | 69 | 5.8 | 100 | |||
|
| ||||||||
| Selected series comparing outcomes of patients underwent NSS or RN for renal masses* | ||||||||
|
| ||||||||
| RN | NSS | RN | NSS | RN | NSS | |||
|
| ||||||||
| Patard et al. | [18] | 2004 | 1075 | 379 | 99 | 99 | 97 | 98 |
| Lee et al. | [27] | 2000 | 183 | 79 | 100 | 100 | 96 | 96 |
| Leibovich et al. | [28] | 2004 | 841 | 91 | 98 | 95 | 86 | 98 |
| McKiernan et al. | [24] | 2002 | 173 | 117 | 99 | 96 | 100 | 100 |
*Median follow-up is >25 months for all studies.
**Median follow-up is >47 months for all studies.
N: Number of patients, dfs: disease-free survival, FU: Follow-up, mos: months.